ADMELOG

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 08cd60f8d5f50e48
Drug Approval Canada Name: ADMELOG
Product Name: ADMELOG
Status: Marketed
Status Date: 2019-11-22
Original Market Date: 2019-11-22
Din: 02469901
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08
Atc Original: A10AB04 INSULIN LISPRO
Atc Name: a 10 ab 04
Aig Number: 0131614001
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

INSULIN LISPRO

100 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

08cd60f8d5f50e48

Type

Standard